Literature DB >> 8449203

Effects of early use of captopril on haemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction.

J Galcera-Tomas1, J A Nuño de la Rosa, G Torres-Martinez, P Rodriguez-Garcia, F J Castillo-Soria, A Canton-Martinez, J V Campos-Peris, F Pico-Aracil, J A Ruiz-Ros, J A Ruiperez-Abizanda.   

Abstract

To determine whether ventricular short-term enlargement following acute myocardial infarction is related to increased left filling pressures and whether early treatment with captopril alters this process we studied 68 patients with a first acute myocardial infarction. Forty patients with a pulmonary capillary pressure equal or above 17 mmHg were randomized to treatment with conventional therapy plus captopril (n 20) or placebo (n 20), in a double blind fashion. The remaining 28 patients (non-dysfunction group) were treated conventionally. During the first 72 h, afterload showed a prompt decrease in the captopril group as compared to placebo. Changes from baseline to 14 days in end-diastolic and end-systolic left ventricular volume indexes determined by radionuclide ventriculography were: non-dysfunction, 85.6 (+/- 21) vs 88 (+/- 20) and 44 (+/- 17) vs 44 (+/- 17) ml.m-2; captopril (n 20), 96.6 (+/- 18) vs 99 (+/- 19) and 66 (+/- 22) vs 65 (+/- 22) ml.m-2; placebo (n 20), 96 (+/- 25) vs 113 (+/- 19) (P < 0.001) and 63 (+/- 18) vs 74 (+/- 22) ml.m-2 (P < 0.01). This study indicates that short-term ventricular enlargement is related to the degree of ventricular dysfunction and that captopril may improve this process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449203     DOI: 10.1093/eurheartj/14.2.259

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

Review 1.  North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-05-02

Review 2.  Clinical aspects of ACE inhibition in patients with acute myocardial infarction.

Authors:  C Borghi; E Ambrosioni
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 3.  Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

4.  Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction : meta-analysis of randomised clinical trials.

Authors:  Antònia Agustí; Sara Bonet; Josep Maria Arnau; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Early ACEI/ARB use and in-hospital outcomes of acute myocardial infarction patients with systolic blood pressure <100 mmHg and undergoing percutaneous coronary intervention: Findings from the CCC-ACS project.

Authors:  Xuedong Zhao; Guanqi Zhao; Mengge Zhou; Ge Wang; Changsheng Ma; Sidney C Smith; Gregg C Fonarow; Louise Morgan; Bin Que; Hui Ai; Jing Liu; Dong Zhao; Shaoping Nie
Journal:  Front Cardiovasc Med       Date:  2022-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.